“I’m not opposed to the concept of equity financing, I believe that preserving equity is fundamental to preserving a Founder’s vision,” said Ryan Saadi, Founder and CEO of Tevogen Bio. “From a ...

The holding company operating in Hong Kong on Friday said it is issuing 1.375 million Class A ordinary shares at an estimated price between $4 and $5 per share. Following the offering, 9.2% of the ...